YGJ-33419-30090
2 vaccinations
3 coded responses
21 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 557 / MN
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Registered in v-safe
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue, Headache, Myalgia — Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessFree text: Muscle aches and fatigue were minimal; headache required meds and alphastim to dissipate.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-03
- 2021-02-11
-
2021-02-17
Dose 2 — Pfizer-BioNTech
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
-
2021-02-24
Health check-in — day 7, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-03
Survey response — day 14, dose 2MedDRA: Asthenia, Dysphonia, Headache, Secretion discharge, Throat irritation — Feeling: FairFree text: Symptoms are allergy-like: scratchy sore throat, minor extra mucous production, raspy voice, low-grade headache. There is no elevated temp, or coughing, but low energy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
-
2021-03-17
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activitiesFree text: From Monday, 15 March, until this afternoon, I experienced a migraine that was finally resolved by OTC meds and use of alphastim. This was longer in duration than the migraine I experienced after the first shot. Am still feeling rather punk.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-26
- 2021-03-31
- 2021-05-19
- 2021-08-18
- 2022-02-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Muscle aches and fatigue were minimal; headache required meds and alphastim to dissipate.
Release 5 — day 14, dose 2
Symptoms: Symptoms are allergy-like: scratchy sore throat, minor extra mucous production, raspy voice, low-grade headache. There is no elevated temp, or coughing, but low energy.
Release 5 — day 28, dose 2
Symptoms: From Monday, 15 March, until this afternoon, I experienced a migraine that was finally resolved by OTC meds and use of alphastim. This was longer in duration than the migraine I experienced after the first shot. Am still feeling rather punk.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Dysphonia | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Secretion discharge | ✓ | ✓ | ✓ |
| SD | Throat irritation | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release